New and developing therapies for celiac disease.

Area of Science:

• Gastroenterology and Immunology
• Celiac Disease Pathogenesis and Therapeutics

Background:

• Celiac disease management primarily relies on a strict gluten-free diet, which presents significant challenges including cost, inconvenience, and adherence difficulties.
• Despite the effectiveness of a gluten-free diet for most patients, the inherent difficulties necessitate the exploration of alternative and complementary therapeutic strategies.

Purpose of the Study:

• To review emerging research and potential alternative therapies for celiac disease beyond the standard gluten-free diet.
• To explore novel therapeutic approaches targeting gluten exposure, intestinal permeability, and immune activation in celiac disease.

Main Methods:

• Review of current and emerging therapeutic strategies for celiac disease.
• Categorization of therapies based on their mechanism of action: decreasing gluten exposure, modifying intestinal permeability, or modulating immune activation.

Main Results:

• Several therapeutic avenues are under investigation, including gluten-digesting enzymes, inhibitors of paracellular permeability, gluten-binding polymers, and modulators of immune responses (e.g., TTG inhibitors, DQ2/DQ8 blockers, cytokine modulators).
• The ideal alternative therapy aims for minimal side effects, comparable to the gluten-free diet, and suitability for both intermittent and chronic use to manage inadvertent gluten exposure.

Conclusions:

• Alternative therapies for celiac disease are actively being developed, offering potential solutions to the limitations of a gluten-free diet.
• Future therapies may provide options for patients to manage the condition more effectively, potentially reducing the burden of strict dietary adherence and mitigating the effects of accidental gluten ingestion.